Non-hormonal steroid modulators of nf-kappa beta for treatment of disease
AssigneeReveraGen BioPharma, Inc.
InventorsJohn M. MCCALL, Eric HOFFMAN, Kanneboyina NAGARAJU, Jesse DAMSKER
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds and methods which may be useful as treatments of diseases.
Claims5
1-10. (canceled)
A method to treat or reduce the symptoms of a disease chosen from uveitis, allergic bronchopulmonary aspergillosis, ankylosing spondylitis, bronchiolitis, mycosis fungoides, nephrotic syndrome, pulmonary fibrosis, sarcoidosis, and thrombocytopenia, comprising the administration, to a patient in need thereof, of a therapeutically effective amount of a compound having the structural formula:
A method to treat or reduce at least one parameter of lung inflammation, comprising the administration, to a patient in need thereof, of a therapeutically effective amount of a compound having the structural formula:
The method of claim 13, wherein the at least one parameter of lung inflammation is chosen from leukocyte infiltration (eosinophils and CD4+ T cells) and mucus production.
A method to treat or reduce at least one symptom of edema, comprising the administration, to a patient in need thereof, of a therapeutically effective amount of a compound having the structural formula:
Dependencies are inferred from the claim text.